International Clinical Trial: A Multicenter, Prospective, Randomized Controlled Study to Explore the Efficacy and Safety of Encapsulated Fecal Microbiota Transplantation with Different Dosing Intervals in the Treatment of Hepatic Encephalopathy

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119644) titled 'A Multicenter, Prospective, Randomized Controlled Study to Explore the Efficacy and Safety of Encapsulated Fecal Microbiota Transplantation with Different Dosing Intervals in the Treatment of Hepatic Encephalopathy' on March 2.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: hulan (Hangzhou) Hospital

Condition: Hepatic encephalopathy

Intervention: High-frequency dosing group:Intervention:Oral encapsulated fecal microbiota transplantation,96 capsules per dose Intervention Time:Baseline and post-cFMT (week 4) Low-frequency dosing group:Intervention:Oral encapsulated fecal microbiota...